Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December

Rhea-AI Summary

Teva (NYSE: TEVA) announced that Richard Francis, president and CEO, and other executive management will present at three investor conferences in early December 2025.

Schedule: Evercore Healthcare Conference on Dec 3, 2025 at 8:20 AM ET; Piper Sandler Healthcare Conference on Dec 3, 2025 at 11:00 AM ET; and Citi 2025 Global Healthcare Conference on Dec 4, 2025 at 10:30 AM ET. Live webcasts will be available via Teva’s Investor Relations website and archived within 24 hours after each live presentation.

TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of executive management will present at three upcoming investor conferences in December as follows:

• 8th Annual Evercore Healthcare Conference
  Wednesday, December 3, 2025, at 8:20 A.M. Eastern Time (ET)
  
  
• Piper Sandler 37th Annual Healthcare Conference
  Wednesday, December 3, 2025, at 11:00 A.M. Eastern Time (ET)
  
  
• Citi’s 2025 Global Healthcare Conference 
  Thursday, December 4, 2025, at 10:30 A.M. Eastern Time (ET)
  
  

To access a live webcast of the presentation, visit Teva’s Investor Relations website at  https://ir.tevapharm.com/Events-and-Presentations.

An archived version of the webcast will be available within 24 hours after the end of the live discussion.

About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements
This Document and the presentation at the conferences may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace, including our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the third quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the section captioned “Risk Factors” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries
TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquires 
TevaIR@Tevapharm.com 

FAQ

When will Teva (TEVA) present at the Evercore Healthcare Conference in December 2025?

Teva will present on Wednesday, December 3, 2025 at 8:20 AM Eastern Time.

What time is Teva’s presentation at the Piper Sandler 37th Annual Healthcare Conference (TEVA)?

Teva’s presentation is scheduled for Wednesday, December 3, 2025 at 11:00 AM Eastern Time.

When does Teva (TEVA) present at Citi’s 2025 Global Healthcare Conference?

Teva will present on Thursday, December 4, 2025 at 10:30 AM Eastern Time.

Who from Teva will speak at the December 2025 investor conferences?

Richard Francis, Teva’s president and CEO, and other members of executive management will present.

How can investors watch Teva’s (TEVA) conference presentations live?

Live webcasts are available on Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.

Will Teva (TEVA) provide an archived replay of the December 2025 presentations?

Yes. An archived version of each webcast will be available within 24 hours after the live discussion ends.